NLS Pharmaceutics AG NLSP

$ 1.91 -19.75%

Annual report 2023
added 12-21-2024

NLS Pharmaceutics AG Balance Sheet 2011-2024 | NLSP

Annual Balance Sheet NLS Pharmaceutics AG

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	220 K	-68.2 K	-	6.68 M	-	-	-	-	-	-
Long Term Debt	-	-	-	313 K	152 K	6.39 M	8.87 M	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	2.99 M	2.83 M	6.54 M	9.02 M	-	-	-	-	-	-
Total Current Liabilities	7.92 M	3.36 M	2.4 M	7.2 M	4.04 M	-	-	-	-	-	-	-	-
Total Liabilities	10.7 M	6 M	5.22 M	10.2 M	6.87 M	8.96 M	10 M	-	-	-	-	-	-
Deferred Revenue	-	265 K	265 K	225 K	225 K	-	-	-	-	-	-	-	-
Retained Earnings	-70.4 M	-58.2 M	-41.7 M	-29.8 M	-26.9 M	-21.5 M	-16.3 M	-	-	-	-	-	-
Total Assets	1.85 M	9.28 M	5.76 M	1.21 M	696 K	146 K	2.29 M	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	93.7 K	220 K	-	-	-	-	-	-	-	-
Book Value	-8.83 M	3.28 M	542 K	-8.98 M	-6.17 M	-8.81 M	-7.72 M	-	-	-	-	-	-
Total Shareholders Equity	-8.83 M	3.28 M	542 K	-8.98 M	-6.17 M	-8.81 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet NLS Pharmaceutics AG

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	113 K	-	-	-	152 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	5.22 M	-	4.02 M	-	10.2 M	-	-	-	6.87 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	265 K	-	-	-	225 K	-	-	-	225 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-41.7 M	-	-34.4 M	-	-29.8 M	-	-	-	-26.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	5.76 M	-	8.27 M	-	1.21 M	-	-	-	696 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	5.43 M	-	7.09 M	-	93.7 K	-	145 K	-	220 K	-	-	-	6.68 K	-	-	-	2.18 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	542 K	-	4.25 M	-	-8.98 M	-	-	-	-6.17 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	542 K	-	4.25 M	-	-8.98 M	-	-7.33 M	-	-6.17 M	-	-	-	-8.81 M	-	-	-	-7.72 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency